| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_372e95218ce5cfaec5ceb1df2371e85c
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_5a0770b189f53ee9269259af015ee2b9
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_e4b62d19195f057d358b8a7768994862
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_f7127971b78c612b8dadd444077feaaa
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_1f6b1a62ecdd54645b29bb3cc95c9f47
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_5f25958849627bc1e17cf969904dd0b3
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_8309934ab672533d450bfcd6f50f0d3f |
| classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K47-32
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K47-10 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P17-02
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-0014
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P17-06
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-58
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-06 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-58 |
| filingDate |
2008-04-09-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_5b20a78dbb12a23fea9a4c2a3aad3f1f
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_d428fd5f722af6ac9432158b71db2019
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_b5cfecc1fac05c97a3681a7df8145eaa
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_d285032bd4e7628d734a8b25970f34f8
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_4c5b3aca4ad1802e62c14758f098fbd8
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_e163b0c8cba0bc988acb76e8d0233f7a |
| publicationDate |
2010-02-25-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
WO-2008126076-A3 |
| titleOfInvention |
Low-dose mometasone formulations |
| abstract |
Provided is a topical cream composition for the delivery of mometasone furoate comprising low dose mometasone furoate for the treatment of corticosteroid responsive dermatoses. The composition of the present invention can be safely applied over large surface areas of the skin (including areas with wrinkles and/or hair), and can be used therapeutically for extended periods of time (e.g., greater than 3 weeks). Treatment with the composition of the present invention carries reduced and/or fewer side effects compared with commercially available mometasone furoate cream products. The cream composition of the present invention is safe for the use of babies and infants under 2 years old. Additionally provided are methods of preparing and using the composition of the invention. |
| priorityDate |
2007-04-11-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |